Research Articles
Unlocking Diabetes Secrets: How Metformin Rewrites Your Genetic Code
Explore how metformin modulates epigenetic regulators like DNMT1, TET1, OGG1, and AID genes in type 2 diabetes treatment.
An Old Drug's New Trick: Turning Cancer's Survival Signal Into a Death Warrant
Discover how metformin, a common diabetes drug, triggers cancer cell death by activating the ROS-AMPK-ULK1 signaling pathway through AXL mediation in esophageal adenocarcinoma.
Beyond Blood Sugar: How Metformin Surprises Scientists With Its Cholesterol-Lowering Power
Discover how metformin, a common diabetes drug, lowers cholesterol through ChREBP-mediated PCSK9 regulation, revealing new connections between glucose and cholesterol metabolism.
The Sugar Shield: How a Common Diabetes Drug is Protecting Kidneys
Discover how metformin, a common diabetes drug, actively protects kidneys by regulating insulin signaling pathways and preventing diabetic nephropathy.
The Genetic Lottery: Why Metformin Works for Some But Not Others
Discover how genetic variants in CPA6, PRPF31, and STAT3 genes influence metformin response in type 2 diabetes patients and the future of personalized medicine.